Background: Previous reports indicate an association between Epstein-Barr virus (EBV)
antibody levels and multiple sclerosis (MS) disease activity, but the results have been …

Abstract Background Anti-Epstein–Barr virus (EBV) nuclear antigen-1 (anti-EBNA-1) IgG
antibody titres have been found to correlate with MRI and clinical measures of disease …

In this study, the prevalence and reactivity of anti-Epstein-Barr virus (EBV) antibodies were
investigated in 107 patients with multiple sclerosis (MS) in comparison to age-and gender …

Background Female gender, human leukocyte antigen (HLA) DR2, tobacco smoking and
Epstein-Barr virus (EBV) are established risk factors for multiple sclerosis (MS). Their …

Background: Evidence suggests that Epstein-Barr virus (EBV) plays a role in triggering or
perpetuating disease activity in multiple sclerosis (MS). Methods: We investigated 100 …

Background: Sero‐epidemiological studies have demonstrated the association between
multiple sclerosis (MS) and prior Epstein–Barr virus (EBV) infection. It has been …

Background: Our objective was to determine whether antibodies against the Epstein–Barr
virus (EBV) nuclear antigen‐1 (EBNA‐1), early antigen (EA), and EBV neutralizing …

Objectives: To study in relapsing–remitting (RR) multiple sclerosis (MS) whether
exacerbations and brain activity as measured by magnetic resonance imaging (MRI) are …

ContextInfection with Epstein-Barr virus (EBV) has been associated with an increased risk of
multiple sclerosis (MS), but the temporal relationship remains unclear. ObjectiveTo …

To characterize the antibody response to the Epstein-Barr virus (EBV) in MS, we studied
serum anti-EBV nuclear antigen (anti-EBNA) and anti-EBV capsid antigen (anti-EBVC A) …